LXRX - Lexicon Pharmaceuticals GAAP EPS of -$0.13 November, 09 2022 04:03 PM Lexicon Pharmaceuticals Inc. Lexicon Pharmaceuticals press release ( NASDAQ: LXRX ): Q3 GAAP EPS of -$0.13. As of September 30, 2022, Lexicon had $136.2 million in cash and investments, as compared to $86.7 million as of December 31, 2021 For further details see: Lexicon Pharmaceuticals GAAP EPS of -$0.13